The Anti-CD40L (Ruplizumab) Biosimilar MAb (HDBS0042) offered by Assay Genie is a monoclonal antibody designed for research involving CD40L, a key molecule in immune regulation. This biosimilar to Ruplizumab is highly reactive with human samples and is validated for use in various applications, including Western blotting.CD40L, also known as CD154, plays a crucial role in the activation of immune responses and the regulation of immune cell interactions. Dysregulation of CD40L signaling has been implicated in various autoimmune diseases, making it a valuable target for research into potential therapies.
By using the Anti-CD40L (Ruplizumab) Biosimilar MAb (HDBS0042), researchers can study the function and expression of CD40L in different cell types, providing valuable insights into its role in immune responses and potential therapeutic interventions. This antibody is a valuable tool for studies in immunology, autoimmune diseases, and cancer research.
Product Name:
Ruplizumab (Anti-CD40L) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0042
Target:
CD40 Ligand
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BG-9588, hu5c8
Description:
Anti-CD40L (ruplizumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
